Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-11

Clinical Trial Update: DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing DEXTENZA to prednisone acetate 1% for macular edema with diabetic retinopathy after cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza (Dexamethasone)
  • Prednisolone Acetate 1% (prednisolone acetate)

Snippet

Sponsor: Ophthalmic Consultants of the Capital Region | Conditions: Retinopathy, Diabetic | Phase 4 | Status: UNKNOWN